Simulation model shows potential clinical value of Eisai drug for patients with early AD

Retrieved on: 2022-09-29 07:31:14

Tags for this article:

Click the tags to see associated articles and topics

Simulation model shows potential clinical value of Eisai drug for patients with early AD. View article details on hiswai:

Excerpt

Lecanemab is an investigational humanized monoclonal antibody for Alzheimer's disease (AD) that is the result of a strategic research alliance ...

Article found on: www.biopharma-reporter.com